Vienna, Austria

Robert Konrat

This inventor holds 5 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Cebina Gmbh, Universitat Wien, University of Vienna. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Konrat. Retrieved from https://idiyas.com/inventor/robert-konrat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 60.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Konrat

Introduction

Robert Konrat is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of antiviral treatments, particularly in the fight against coronavirus. With a total of 5 patents to his name, Konrat's work is paving the way for new therapeutic methods.

Latest Patents

Konrat's latest patents focus on antiviral treatments utilizing Azelastine compounds. One of his patents describes a method of treating subjects in need of anti-coronavirus treatment by providing a prophylactic or therapeutic treatment that includes an antiviral effective amount of an Azelastine compound. The specified dosage ranges from 0.1 to 500 µg per dose. Additionally, he has developed methods for using Azelastine compounds as antiviral substances in medicinal products aimed at treating biological surfaces to prevent coronavirus infection and spread. These compounds can also serve as viral disinfectants.

Career Highlights

Throughout his career, Robert Konrat has worked with reputable organizations such as Cebina GmbH and Universität Wien. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in antiviral treatments.

Collaborations

Konrat has collaborated with notable colleagues, including Eszter Nagy and Gabor Nagy. Their joint efforts have further enhanced the research and development of antiviral solutions.

Conclusion

Robert Konrat's innovative work in antiviral treatments demonstrates his commitment to addressing pressing health challenges. His contributions are vital in the ongoing battle against viral infections, particularly in the context of the coronavirus pandemic.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…